Company Filing History:
Years Active: 2016-2025
Title: Aki Tomiki: Innovator in Enzymatic Technologies
Introduction
Aki Tomiki, an accomplished inventor based in Chiba, Japan, has made significant contributions to the field of enzymatic technologies. With a portfolio of nine patents, Tomiki's innovations have a profound impact on the biotechnology industry.
Latest Patents
Among his latest inventions, one noteworthy patent is focused on polypeptides exhibiting pullulanase activity, which are suitable for use in liquefaction processes. This invention describes a variant pullulanase that demonstrates increased thermo-stability and thermo-activity compared to its parent variant. The patent details specific substitutions at key amino acid positions to enhance the enzyme's effectiveness in liquefying starch-containing materials at elevated temperatures.
Another significant patent introduced by Tomiki revolves around serine protease variants, showcasing improved properties compared to the parent protease. This invention emphasizes variants belonging to family 53, derived from a specific strain, which exhibit remarkable thermal stability, including enhanced residual activity after exposure to high temperatures. The advancements achieved through these innovations have critical applications in various industrial processes.
Career Highlights
Aki Tomiki currently works at Novozymes A/S, a leading company in the field of biotechnology. His work focuses on developing cutting-edge enzymes that facilitate various biotechnological applications. Throughout his career, Tomiki has remained committed to advancing enzymatic technology, making him a notable figure in the field.
Collaborations
Tomiki has worked alongside talented colleagues, including Tomoko Matsui and Keiichi Ayabe, combining their expertise to foster innovative research and development. Together, they have contributed to the success of their projects and the advancement of enzymatic capabilities at their company.
Conclusion
In summary, Aki Tomiki stands out as a prominent inventor within the biotechnology sector, with a notable focus on developing innovative enzymatic solutions. His recent patents demonstrate a commitment to enhancing the stability and efficacy of enzymes, ultimately benefitting various industries reliant on these biotechnological advancements.